Current position:Home >Product >
4-bromanyl-N-[4-(1-cyclopropylcarbonyl-2-methyl-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl]benzamide
4-bromanyl-N-[4-(1-cyclopropylcarbonyl-2-methyl-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl]benzamide
|
|
Canonical SMILES:
CC1CC2=C(N1C(=O)C3CC3)C=CC(=C2)C4=CSC(=N4)NC(=O)C5=CC=C(C=C5)Br
Isomeric SMILES
CC1CC2=C(N1C(=O)C3CC3)C=CC(=C2)C4=CSC(=N4)NC(=O)C5=CC=C(C=C5)Br
InChI
InChI=1S/C23H20BrN3O2S/c1-13-10-17-11-16(6-9-20(17)27(13)22(29)15-2-3-15)19-12-30-23(25-19)26-21(28)14-4-7-18(24)8-5-14/h4-9,11-13,15H,2-3,10H2,1H3,(H,25,26,28)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- N-[2-(tert-butylamino)-2-oxidanylidene-1-phenyl-ethyl]-2,4-dimethyl-N-prop-2-enyl-1,3-thiazole-5-carboxamide
- N-[4-(1-cyclopropylcarbonyl-2-methyl-2,3-dihydroindol-5-yl)-5-methyl-1,3-thiazol-2-yl]-2-phenoxy-ethanamide
- N-[2-(cyclopentylamino)-2-oxidanylidene-1-phenyl-ethyl]-2,4-dimethyl-N-(thiophen-2-ylmethyl)-1,3-thiazole-5-carboxamide
- N-[4-(1-cyclopropylcarbonyl-2-methyl-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl]-3,4,5-trimethoxy-benzamide
- N-[4-(1-cyclopropylcarbonyl-2-methyl-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl]-2-thiophen-2-yl-ethanamide
- N-[2-(cyclopentylamino)-2-oxidanylidene-1-phenyl-ethyl]-2,4-dimethyl-N-(4-methylphenyl)-1,3-thiazole-5-carboxamide
- N-[2-(cyclopentylamino)-2-oxidanylidene-1-pyridin-4-yl-ethyl]-2,4-dimethyl-N-(3-methylphenyl)-1,3-thiazole-5-carboxamide
- N-[2-(cyclopentylamino)-2-oxidanylidene-1-phenyl-ethyl]-2,4-dimethyl-N-(phenylmethyl)-1,3-thiazole-5-carboxamide
- N-[2-(cyclopentylamino)-2-oxidanylidene-1-phenyl-ethyl]-2,4-dimethyl-N-phenyl-1,3-thiazole-5-carboxamide
- N-[2-(cyclopentylamino)-2-oxidanylidene-1-phenyl-ethyl]-2,4-dimethyl-N-pyridin-3-yl-1,3-thiazole-5-carboxamide

